Catherine Winbanks specialises in patent matters for the biotechnology, pharmaceutical, agricultural and life sciences sectors. Catherine practises in prosecuting and overseeing patent portfolios for local and international biotechnology companies and also works with research institutes and foreign patent attorneys. She assists clients in aspects of patent practice including drafting, prosecution, oppositions, patentability, freedom to operate matters, and IP portfolio strategy.
Prior to becoming a Patent Attorney, Catherine completed her PhD on molecular pathways in the pathogenesis of renal fibrosis. Following her PhD, she completed post-doctoral research at the University of Melbourne and the Baker Heart and Diabetes Institute. This research included studying Wnt/beta-catenin in the development of colorectal cancer. She also interrogated the roles of the TGF-beta and BMP pathways in skeletal muscle disease, cardiovascular related diseases and diabetes using an adeno-associated viral (AAV) technology platform. She has also characterised the role of miRNA in regulating the chromatin state of histone deacetylases. Catherine’s broad range of scientific expertise places her in a strong position to assist her clients with their intellectual property needs.